Product image of Lacosamide Doc (Lacosamide) supplied by GNH India

Lacosamide Doc

Active Ingredient:
Lacosamide
Origin:
EU

Lacosamide Doc (Lacosamide)

Lacosamide, the active ingredient in Lacosamide Doc, is an anti‑epileptic presented as an oral formulation for oral use. It is used to treat partial‑onset seizures in patients who require adjunctive therapy.
GNH India supplies Lacosamide Doc as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Doc Generici S.R.L.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Lacosamide is an anti‑epileptic that acts on neuronal sodium channels to control seizure activity.

  • Partial‑onset seizures: reduces seizure frequency when added to existing antiseizure regimens.
  • Focal onset seizures: improves overall seizure control as adjunctive therapy.

How It Works

  • Lacosamide enhances the slow inactivation of voltage‑gated sodium channels, stabilizing hyper‑excitable neuronal membranes. It also binds to collapsin response mediator protein‑2 (CRMP2), modulating neuronal excitability and reducing the propagation of epileptic discharges.

Side Effects

Lacosamide may cause a range of adverse reactions, most of which are mild to moderate in severity.

Common Side Effects

  • Dizziness: sensation of light‑headedness or unsteadiness.
  • Nausea: mild to moderate stomach upset.
  • Headache: intermittent pain in the head region.
  • Fatigue: feeling unusually tired or weak.
  • Vision disturbances: blurred or double vision.
  • Tremor: involuntary shaking of limbs.

Serious or Rare Side Effects

  • Cardiac arrhythmia: irregular heart rhythm, including PR‑interval prolongation.
  • Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis.
  • Suicidal thoughts: emergence of depressive symptoms or suicidal ideation.
  • Liver enzyme elevation: significant increase in hepatic transaminases.
  • Hypersensitivity: anaphylactic reactions or severe allergic response.

Precautions & Warnings

Patients and prescribers should consider several safety measures when using Lacosamide.

  • Cardiac monitoring: assess ECG for PR‑interval changes before and during therapy.
  • Renal function: adjust dose in patients with severe renal impairment.
  • Hepatic function: monitor liver enzymes periodically.
  • Pregnancy: avoid use unless benefits outweigh potential risks, as safety data are limited.
  • Concomitant CNS depressants: use caution as additive sedation may occur.
  • Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture.

Avoid Interactions

Lacosamide can interact with other medicines, influencing its efficacy or safety.

Major Interactions (Avoid)

  • Carbamazepine: may reduce lacosamide plasma levels, decreasing effectiveness.
  • Phenytoin: can lower lacosamide concentrations, risking seizure breakthrough.
  • CYP2C19 inhibitors (e.g., fluconazole): may increase lacosamide exposure, raising toxicity risk.

Moderate Interactions (Monitor Closely)

  • Other sodium‑channel blockers (e.g., lamotrigine): may enhance central nervous system side effects.
  • Opioids or benzodiazepines: additive sedation or respiratory depression.
  • Anticoagulants (e.g., warfarin): monitor INR as lacosamide may affect metabolism.

Frequently Asked Questions

Lacosamide Doc is prescribed as an adjunctive therapy for partial‑onset (focal) seizures in patients with epilepsy. It helps reduce the frequency of seizures when added to existing antiseizure medications, improving overall seizure control.

Lacosamide enhances the slow inactivation of voltage‑gated sodium channels, stabilizing neuronal membranes and preventing repetitive firing. It also binds to CRMP2, a protein involved in neuronal excitability, further contributing to seizure suppression.

The dosage of Lacosamide Doc is individualized. A qualified prescriber determines the appropriate dose based on the patient’s clinical condition, response, and any renal or hepatic considerations. Patients should follow the prescribing information provided by their healthcare professional.

Safety data for lacosamide in pregnancy are limited, and the pregnancy category is unknown. It should only be used if the potential benefit justifies the potential risk to the fetus. Breastfeeding decisions should be made in consultation with a healthcare provider.

To order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and necessary import documentation.

Lacosamide’s unique mechanism—enhancing slow sodium‑channel inactivation and binding CRMP2—differs from many traditional antiseizure medicines that target fast inactivation. This can offer an alternative for patients who have inadequate response or intolerable side effects with other agents.

Store Lacosamide Doc at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture, and avoid exposure to direct sunlight or extreme heat to maintain stability.

Lacosamide Doc is taken orally, usually as tablets or oral solution, as directed by the prescriber. It should be swallowed whole with water and can be taken with or without food, according to the healthcare professional’s instructions.

Serious risks include cardiac arrhythmias such as PR‑interval prolongation, severe skin reactions like Stevens‑Johnson syndrome, and rare cases of suicidal thoughts. Patients should be monitored for these events and seek immediate medical attention if they occur.

Lacosamide should be avoided in patients with known hypersensitivity to the drug or its excipients, and in those with significant cardiac conduction disorders unless closely monitored. Individuals with severe renal impairment may require dose adjustment or alternative therapy.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Lacosamide

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT